WO2004000994A2 - Nouveau gene de l'acetylcholinesterase responsable de la resistance aux insecticides et ses applications - Google Patents
Nouveau gene de l'acetylcholinesterase responsable de la resistance aux insecticides et ses applications Download PDFInfo
- Publication number
- WO2004000994A2 WO2004000994A2 PCT/FR2003/001876 FR0301876W WO2004000994A2 WO 2004000994 A2 WO2004000994 A2 WO 2004000994A2 FR 0301876 W FR0301876 W FR 0301876W WO 2004000994 A2 WO2004000994 A2 WO 2004000994A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- seq
- lab
- kisumu
- yao
- sequence
- Prior art date
Links
- 108010022752 Acetylcholinesterase Proteins 0.000 title claims abstract description 119
- 230000012865 response to insecticide Effects 0.000 title description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 96
- 101150111329 ACE-1 gene Proteins 0.000 claims abstract description 70
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 69
- 239000002917 insecticide Substances 0.000 claims abstract description 65
- 241000255925 Diptera Species 0.000 claims abstract description 61
- 239000002299 complementary DNA Substances 0.000 claims abstract description 28
- 150000004657 carbamic acid derivatives Chemical class 0.000 claims abstract description 26
- 238000001514 detection method Methods 0.000 claims abstract description 20
- 238000012216 screening Methods 0.000 claims abstract description 18
- 239000012634 fragment Substances 0.000 claims description 155
- 102100033639 Acetylcholinesterase Human genes 0.000 claims description 115
- 241000256059 Culex pipiens Species 0.000 claims description 75
- 241000238631 Hexapoda Species 0.000 claims description 58
- 230000035772 mutation Effects 0.000 claims description 50
- 229940022698 acetylcholinesterase Drugs 0.000 claims description 42
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 40
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 34
- 230000003197 catalytic effect Effects 0.000 claims description 34
- 241000256182 Anopheles gambiae Species 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 29
- 150000001413 amino acids Chemical group 0.000 claims description 28
- 230000000694 effects Effects 0.000 claims description 28
- 108020004707 nucleic acids Proteins 0.000 claims description 21
- 102000039446 nucleic acids Human genes 0.000 claims description 21
- 150000007523 nucleic acids Chemical class 0.000 claims description 21
- 239000013598 vector Substances 0.000 claims description 21
- 241001465754 Metazoa Species 0.000 claims description 20
- 238000006467 substitution reaction Methods 0.000 claims description 20
- 239000004471 Glycine Substances 0.000 claims description 19
- 239000000126 substance Substances 0.000 claims description 19
- 108010033276 Peptide Fragments Proteins 0.000 claims description 17
- 102000007079 Peptide Fragments Human genes 0.000 claims description 17
- 238000004458 analytical method Methods 0.000 claims description 16
- 230000029087 digestion Effects 0.000 claims description 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 14
- 230000009261 transgenic effect Effects 0.000 claims description 12
- ISRUGXGCCGIOQO-UHFFFAOYSA-N Rhoden Chemical compound CNC(=O)OC1=CC=CC=C1OC(C)C ISRUGXGCCGIOQO-UHFFFAOYSA-N 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 11
- 241000256054 Culex <genus> Species 0.000 claims description 8
- 230000000749 insecticidal effect Effects 0.000 claims description 8
- 239000000523 sample Substances 0.000 claims description 8
- 238000012360 testing method Methods 0.000 claims description 8
- 230000003321 amplification Effects 0.000 claims description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 7
- 108091008146 restriction endonucleases Proteins 0.000 claims description 7
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims description 6
- 239000003112 inhibitor Substances 0.000 claims description 6
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 claims description 5
- 229960004373 acetylcholine Drugs 0.000 claims description 5
- 241000256111 Aedes <genus> Species 0.000 claims description 4
- 241000256186 Anopheles <genus> Species 0.000 claims description 4
- 241000256113 Culicidae Species 0.000 claims description 4
- 239000012472 biological sample Substances 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 238000005259 measurement Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 230000005764 inhibitory process Effects 0.000 claims description 3
- 230000000692 anti-sense effect Effects 0.000 claims description 2
- 230000000295 complement effect Effects 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000004083 survival effect Effects 0.000 claims description 2
- 238000012795 verification Methods 0.000 claims description 2
- 102100034184 Macrophage scavenger receptor types I and II Human genes 0.000 claims 3
- 101710134306 Macrophage scavenger receptor types I and II Proteins 0.000 claims 3
- 101100161682 Anopheles gambiae Ace gene Proteins 0.000 claims 2
- 241001599018 Melanogaster Species 0.000 abstract description 4
- 230000002068 genetic effect Effects 0.000 abstract description 4
- 235000018102 proteins Nutrition 0.000 description 65
- 239000002773 nucleotide Substances 0.000 description 51
- 125000003729 nucleotide group Chemical group 0.000 description 51
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 32
- 235000001014 amino acid Nutrition 0.000 description 28
- 210000004027 cell Anatomy 0.000 description 23
- 125000003275 alpha amino acid group Chemical group 0.000 description 21
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 20
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 18
- 101150100998 Ace gene Proteins 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 17
- 241000256118 Aedes aegypti Species 0.000 description 12
- 101710108761 Acetylcholinesterase-1 Proteins 0.000 description 11
- 241000255601 Drosophila melanogaster Species 0.000 description 10
- 241000722027 Schizaphis graminum Species 0.000 description 10
- 241000894007 species Species 0.000 description 9
- 241000251468 Actinopterygii Species 0.000 description 7
- 241000256187 Anopheles albimanus Species 0.000 description 7
- 241000239223 Arachnida Species 0.000 description 7
- 108020004705 Codon Proteins 0.000 description 7
- 108700024394 Exon Proteins 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 7
- 241000257159 Musca domestica Species 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 241000258916 Leptinotarsa decemlineata Species 0.000 description 5
- 239000011543 agarose gel Substances 0.000 description 5
- 230000004075 alteration Effects 0.000 description 5
- 210000004899 c-terminal region Anatomy 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 4
- 108700028369 Alleles Proteins 0.000 description 4
- 241000238421 Arthropoda Species 0.000 description 4
- 241000251571 Ciona intestinalis Species 0.000 description 4
- 241000500138 Ciona savignyi Species 0.000 description 4
- 229930186217 Glycolipid Natural products 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- 241000257166 Lucilia cuprina Species 0.000 description 4
- 241000244206 Nematoda Species 0.000 description 4
- 241000358422 Nephotettix cincticeps Species 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 3
- 241000238680 Rhipicephalus microplus Species 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 241000607479 Yersinia pestis Species 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- 230000001713 cholinergic effect Effects 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000000575 pesticide Substances 0.000 description 3
- 230000001323 posttranslational effect Effects 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 241000256173 Aedes albopictus Species 0.000 description 2
- 241000167896 Anopheles darlingi Species 0.000 description 2
- 241001414900 Anopheles stephensi Species 0.000 description 2
- 241001600408 Aphis gossypii Species 0.000 description 2
- 241000256844 Apis mellifera Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000255625 Brachycera Species 0.000 description 2
- 241000251538 Branchiostoma lanceolatum Species 0.000 description 2
- 241000272081 Bungarus fasciatus Species 0.000 description 2
- 241000244201 Caenorhabditis briggsae Species 0.000 description 2
- 241000244203 Caenorhabditis elegans Species 0.000 description 2
- 102000004308 Carboxylic Ester Hydrolases Human genes 0.000 description 2
- 108090000863 Carboxylic Ester Hydrolases Proteins 0.000 description 2
- 102000003914 Cholinesterases Human genes 0.000 description 2
- 108090000322 Cholinesterases Proteins 0.000 description 2
- 241000251569 Ciona Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 241001147669 Dictyocaulus viviparus Species 0.000 description 2
- 241001653750 Doryteuthis opalescens Species 0.000 description 2
- 241000277305 Electrophorus electricus Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 241000237852 Mollusca Species 0.000 description 2
- 241001413575 Moorea Species 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- 241000251752 Myxine glutinosa Species 0.000 description 2
- 241000255932 Nematocera Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 241001481704 Rhipicephalus appendiculatus Species 0.000 description 2
- 241000864246 Rhipicephalus decoloratus Species 0.000 description 2
- 108010006886 Vitrogen Proteins 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 210000004900 c-terminal fragment Anatomy 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 229940048961 cholinesterase Drugs 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000000302 molecular modelling Methods 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 238000013081 phylogenetic analysis Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000037432 silent mutation Effects 0.000 description 2
- 230000016978 synaptic transmission, cholinergic Effects 0.000 description 2
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 2
- 239000013603 viral vector Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 229940124596 AChE inhibitor Drugs 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 240000001606 Adenanthera pavonina Species 0.000 description 1
- 235000011470 Adenanthera pavonina Nutrition 0.000 description 1
- 241000878022 Anopheles funestus Species 0.000 description 1
- 241001100970 Anopheles nili Species 0.000 description 1
- 241000205563 Anopheles pseudopunctipennis Species 0.000 description 1
- 241001249681 Anopheles sacharovi Species 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 241001490249 Bactrocera oleae Species 0.000 description 1
- 241000251534 Branchiostoma Species 0.000 description 1
- 241000251535 Branchiostoma floridae Species 0.000 description 1
- 101800001415 Bri23 peptide Proteins 0.000 description 1
- 101800000655 C-terminal peptide Proteins 0.000 description 1
- 102400000107 C-terminal peptide Human genes 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 102100036806 Carboxylesterase 5A Human genes 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 241000270281 Coluber constrictor Species 0.000 description 1
- 241000199632 Craniata <brachiopoda> Species 0.000 description 1
- 241000256057 Culex quinquefasciatus Species 0.000 description 1
- 241000144212 Culex torrentium Species 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- 241001466109 Deuterostomia Species 0.000 description 1
- 101000801359 Homo sapiens Acetylcholinesterase Proteins 0.000 description 1
- 108700011325 Modifier Genes Proteins 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 241000721621 Myzus persicae Species 0.000 description 1
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 1
- BEKQPDFPPJFVJP-AHSQCEKMSA-N Onchidal Chemical compound CC(=O)O\C=C\C(\C=O)=C/CC1C(=C)CCCC1(C)C BEKQPDFPPJFVJP-AHSQCEKMSA-N 0.000 description 1
- JLVLVOITZSLHPU-UHFFFAOYSA-N Onchidal Natural products CC(=O)OC(=CC(=C/CC1C(=C)CCCC1(C)C)C=O)C JLVLVOITZSLHPU-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000275475 Praia Species 0.000 description 1
- 101800004937 Protein C Proteins 0.000 description 1
- 101800001700 Saposin-D Proteins 0.000 description 1
- 102400000827 Saposin-D Human genes 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000251733 Tetronarce californica Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 241000251555 Tunicata Species 0.000 description 1
- 241000710886 West Nile virus Species 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 238000003277 amino acid sequence analysis Methods 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 102220427208 c.233T>C Human genes 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000544 cholinesterase inhibitor Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- OQZCSNDVOWYALR-UHFFFAOYSA-N flurochloridone Chemical compound FC(F)(F)C1=CC=CC(N2C(C(Cl)C(CCl)C2)=O)=C1 OQZCSNDVOWYALR-UHFFFAOYSA-N 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000007653 larval development Effects 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 238000011392 neighbor-joining method Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 210000000715 neuromuscular junction Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 229960000856 protein c Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000008261 resistance mechanism Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 238000003041 virtual screening Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01007—Acetylcholinesterase (3.1.1.7)
Definitions
- the present invention relates to a new acetylcholinesterase gene responsible for resistance to insecticides, in particular in mosquitoes, to the products of this gene (cDNA, protein) and to their applications, in particular for the screening of new insecticides and genetic detection of resistance to organophosphates and / or carbamates in mosquito populations.
- Acetylcholinesterase (AChE, E.C. 3.1.1.7) is an essential enzyme which hydrolyzes acetylcholine in synapses, thereby ending cholinergic transmissions at neuronal or neuromuscular junctions. The inhibition of AChE prevents the deactivation of the synaptic signal, thus leading to a loss of control of cholinergic transmission.
- the first ace gene was identified in Drosophila (Drosophila melanogaster), by reverse genetics (Hall et al., EMBO J., 1986, 5, 2949-2954). Evidence that this gene was involved in insecticide resistance was provided by the demonstration of amino acid substitutions in the AChE of resistant Drosophila, conferring insensitivity to cholinergic insecticides (Mutéro et al., PNAS, 1994 , 91, 5922-5926). Studies in D. melanogaster therefore seemed to indicate the presence of a single ace gene in insects, coding for the AChE target of cholinergic insecticides.
- Musca domestica (Williamson et al., 1992, In Multidisciplinary approaches to cholinesterase functions, Eds Schaffer an A. & Velan B., Plénum Press, New York, pp 83 -86; Walsh et al., Biochem. J., 2001, 359, 175-181; Kozaki et al., Insect. Biochem. Mol.
- a second ace gene has been isolated from arachnids; however, this gene is not involved in resistance to insecticides (Hernandez et al., Baxter et al., cited above). - A second ace gene could not be isolated from insects despite numerous attempts in different species (Menozzi et al., Tomita et al., Mori et al, cited above; Severson et al, J. Hered., 1997, 88 , 520-524).
- the inventors identified a new locus of the ace gene in the genome of Anopheles gambiae and of 15 different species of mosquitoes and they showed that this new locus, non-homologous to the locus previously described in D. melanogaster, was involved in resistance. insecticides in mosquitoes.
- the inventors have also shown that resistance to insecticides, at least in mosquitoes of the species Culex pipiens and Anopheles gambiae, was linked to a single mutation in the acetylcholinesterase sequence encoded by this new gene, located in the vicinity of the catalytic site of the enzyme.
- This new gene represents a diagnostic tool for the genetic detection of resistance to insecticides (organophosphates, carbamates) in mosquito populations.
- the AChE encoded by this gene represents a target for the screening of new active molecules on mosquito populations resistant to the insecticides currently used.
- a subject of the present invention is therefore a protein, characterized in that it comprises a central catalytic region which has an amino acid sequence selected from the group consisting of the sequence SEQ ID NO: 1 and the sequences having at least 60% identity or 70% similarity with the sequence SEQ ID NO: 1, excluding the NCBI sequence AAK0973 corresponding to the acetylcholinesterase of Schizaphis graminum.
- the protein according to the invention represents a new insect acetylcholinesterase, hereinafter referred to as AchEl, responsible for resistance to organophosphates and / or to carbamates, at least in mosquitoes, in particular in C.
- ace-1 the locus coding for said AchEl is hereinafter called ace-1
- ace-2 represents the second ace locus, which is not involved in insecticide resistance in mosquitoes.
- said central catalytic region contains the catalytic domain of AChE and corresponds to that located at positions 70 and 593 of the AChEl sequence of Anopheles gambiae (SEQ ID NO: 3, 643 amino acids ); it corresponds to that located respectively at positions 100 and 629 of the AChEl sequence of Schizaphis graminum (NCBI AAK0973), 60 and 582 of the AChE 1 sequence of Culex pipiens (SEQ ID NO: 7), 34 and 593 of the sequence of Anopheles gambiae AChE2 (FIG. 1, SEQ ID NO: 53), and 41 and 601 of the AChE2 sequence of Drosophila melanogaster (NCBI AAF54915).
- This central region which contains the catalytic domain is conserved in vertebrates and invertebrates while the N- and C-terminal ends show a high variability between the different species.
- the identity of a sequence with respect to a reference sequence is assessed as a function of the percentage of amino acid residues which are identical, when the sequences corresponding to the catalytic region as defined above are aligned, so as to obtain the maximum correspondence between them.
- a protein having an amino acid sequence having at least X% identity with the reference sequence SEQ ID NO: 1 is defined, in the present invention as a protein whose sequence corresponds to the central catalytic region as defined above. above may include up to 100-X alterations per 100 amino acids of the sequence SEQ BD NO: 1.
- alteration includes deletions, substitutions or consecutive or dispersed insertions of amino acids in the reference sequence. This definition applies, by analogy, to nucleic acid molecules.
- the similarity of a sequence with respect to the reference sequence SEQ ID NO 1 is assessed according to the percentage of amino acid residues which are identical or which differ by conservative substitutions, when the sequences corresponding to the central catalytic region as defined above are aligned so as to obtain the maximum of conespondance between them.
- conservative substitution is intended to mean the substitution of one amino acid with another which has similar chemical properties (size, charge or polarity), which generally does not modify the functional properties of the protein.
- a protein having an amino acid sequence having at least X% similarity to the sequence SEQ ID NO: 1 is defined, in the present invention as a protein, the sequence of which corresponds to the central catalytic region as defined above. may include up to 100-X non-conservative alterations per 100 amino acids of the reference sequence.
- non-conservative alterations includes deletions, non-conservative substitutions or consecutive or dispersed insertions of amino acids in the sequence SEQ ID NO: 1.
- insect AChEl sequences have 65-97% identity (79-98% similarity) between them,
- the insect AChE2 sequences have 58-99% identity (73-99% similarity) to each other.
- the phylogenetic analysis of the AChEs of the different animal species shows that the protein sequences of AChEl form a significant autonomous group (bootstrap 795/1000), and that the insect AChEl form a significant distinct subgroup (bootstrap 856/1000).
- the AChE 1 comprises patterns characteristic of the AChE (FIG. 1) located at the following positions, respectively in the sequence SEQ ID NO: 3 and in the reference sequence of Tor proceedingsdo californica (SWISSPROT P04058): a canonical motif of the FGESAG type around the serine in position 266 (200), which is characteristic of the active site of AchE, a choline binding site (Tryptophan residue in position 151 (84)), three residues of the catalytic triad (residues serine, glutamic acid and histidine, respectively in positions 266 (200), 392 (327) and 506 (440)), six cysteine residues potentially involved in conserved disulfide bridges ( C ⁇ 34 ( tf7) -Ci6i (-; C 32 o (254) -C 333 (2, 15); 4 68 (02) - 5 s9 (52i)), aromatic residues bordering the throat of the active site (10 residues) and a phen
- AChE 1 is distinguished from the AChE of Drosophila
- the invention encompasses insect AChEl sensitive or resistant to organophosphates and / or carbamates.
- the AChEl sequences include both the primary sequences, as well as the secondary and tertiary sequences of said AChEl.
- sensitive AChE means an AChE whose acetylcholinesterase activity is inhibited in the presence of organophosphates or carbamates.
- resistant AChE means an AChE whose activity is not inhibited by concentrations of organophosphates or carbamates which inhibit 100% of the activity of the corresponding "sensitive AChE” of an individual of the same species; this "resistant AChE” differs from the previous one by the presence of one or more mutations in its amino acid sequence (amino acid substitutions) which modify its sensitivity to acetylcholinesterase inhibitors; among these mutations, the following can be cited F78S, I129V, G227A, F288Y, the amino acids being numbered with reference to the AChE sequence of Torpedo californica (SWISSPROT P04058).
- acetylcholinesterase activity and the catalytic parameters of AChE are measured by standard enzymatic techniques such as those described in Bourguet et al., Cited above.
- the proteins according to the invention include any natural, synthetic, semi-synthetic or recombinant protein of any prokaryotic or eukaryotic organism, comprising or consisting of an amino acid sequence of an AChEl protein as defined above. above. They include proteins isolated from any insect species, as well as recombinant proteins produced in an appropriate expression system.
- said AChEl corresponds to that of an insect which belongs to the order of diptera (Diptera); preferably, said insect is chosen from the family Culicidae, from the genera Culex, Aedes and Anopheles.
- said AChEl consists of the sequences SEQ ID NO: 3, SEQ ID NO: 5 and SEQ ID NO: 126 dAnopheles gambiae and the sequence SEQ ID NO: 7 of Culex pipiens (strain S - LAB), sensitive to organophosphates and / or carbamates.
- said central catalytic region of AChE 1 comprises a sequence selected from the group consisting of sequences SEQ ID NO: 8 to 21 representing a fragment of approximately 91 amino acids (fragment K , Figure 1), corresponding to that located between positions 445 and 535 of the sequence SEQ ID NO: 3.
- said AChEl is an acetylcholinesterase resistant to insecticides from the class of organophosphates and carbamates including a mutation of the glycine located in position 119, into serine (mutation or substitution of type G119S); said position being indicated with reference to the AChE sequence of Torpedo califomica (SWISSPROT P04058).
- the inventors have shown that the residue in position 119 is close to the residues of the catalytic site (serine 200 and histidine 440) and that the replacement of the glycine of AChE 1 of sensitive mosquitoes by a serine, in AChE 1 resistant mosquitoes, reduces the space of the catalytic site and prevents the insecticide from interacting with the catalytic serine (S200), due to the steric hindrance of the Van der Waals bonds of the side chain of the serine in position 119.
- the role of the Gl 19S mutation in insecticide resistance was confirmed by analysis of the acetylcholinesterase activity of the recombinant AChEl proteins produced from the cDNA of sensitive Culex pipiens (strain S-LAB having an AChEl including a glycine in position 119) or resistant (strain SR whose AchEl differs from the previous one only by the presence of a serine in position 119) against insecticides; 90% of the AChE 1 activity of the sensitive strain is inhibited in the presence of 10 ⁇ 3 M propoxur whereas the AChE 1 of the resistant strain retains 75% of its activity in the presence of concentrations 100 times higher of this insecticide (10 "1 M propoxur).
- this embodiment of said resistant AChEl corresponds to that of an insect (resistant to insecticides) which belongs to the order of diptera (Diptera); preferably, said insect is chosen from the family Culicidae, from the genera Culex, Aedes and Anopheles.
- said resistant AChEl has a sequence selected from the group consisting of:
- said AChEl is an acetylcholinesterase sensitive to insecticides from the class of organophosphates and carbamates comprising a sequence selected from the group consisting of SEQ ID NO: 91, 92, 96, 102 to 112, 114, 115 and 117 to 119, representing a fragment of approximately 150 amino acids of the third exon coding for the ace-1 gene derived from an insect as defined above, sensitive to insecticides, said fragment including a glycine in position 119 with reference to the AChE sequence of Toroutheasterndo califomica (SWISSPROT P04058).
- the present invention also relates to a peptide, characterized in that it consists of a fragment of at least 7 amino acids of the protein AChEl, as defined above; these fragments are particularly useful for the production of antibodies specifically recognizing the AChE1 protein.
- the present invention also relates to antibodies, characterized in that they are directed against the AChEl protein or a fragment thereof, as defined above.
- said antibodies are either monoclonal antibodies or polyclonal antibodies.
- the present invention also relates to an isolated nucleic acid molecule, characterized in that it has a sequence selected from the group consisting of:
- the invention encompasses the sequences of the alleles of the ace-1 gene from any insect, as well as the sequences of natural mutants (sensitive and resistant alleles) or artificial mutants of the ace-1 gene coding for a sensitive AChEl protein. or resistant, as defined above.
- said sequence coding for an AChE1 protein is selected from the group consisting of: a) the sequences SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 125,
- SEQ ID NO: 6, SEQ ID NO: 56 and SEQ ID NO: 121 which correspond to the cDNA of the amino acid sequence protein AChEl, respectively SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 126, SEQ ID NO: 7, SEQ ID NO: 57 and SEQ ID NO: 122, as defined above, b) the sequences SEQ ID NO: 22, SEQ ID NO: 23 and SEQ ID NO: 127 which correspond the ace-1 gene of Anopheles gambiae encoding AChEl as defined above, which gene has an exon-infron organization comprising at least 9 exons (Table I), and C) the sequences comprising the sequence SEQ ID NO: 120 which corresponds to the almost complete sequence of the ace-1 gene of Anopheles gambiae encoding the resistant AChEl of sequence SEQ ID NO: 122, as defined above.
- ace-1 gene corresponds to that which is located between intron 4 and intron 5 in the sequence of An, gambiae (Table I), that is to say, in positions 7854 and 8393 of the sequence SEQ ID NO : 127.
- said fragment is selected from the group consisting of primers of sequence SEQ BD NO: 39 to 50, 54, 55, 58, 59, 123, 124, 128 and 129 and the fragments of sequences SEQ ID NO: 24 to 38 and 60 to 89.
- the nucleic acid molecules according to the invention are obtained by the conventional methods, known in themselves, by following standard protocols such as those described in Current Protocols in Molecular Biology (Frederick M. AUSUBEL, 2000, Wiley and son Inc , Library of Congress, USA). For example, they can be obtained by amplification of a nucleic sequence by PCR or RT-PCR, by screening of genomic DNA libraries by hybridization with a homologous probe, or else by total or partial chemical synthesis.
- the nucleic acid molecules as defined above can be used as probes or as primers to isolate the ace-1 gene from other species or alleles of this gene, in particular by screening a genomic DNA library or cDNA, as well as to detect / amplify nucleic acid molecules (mRNA or genomic DNA) encoding an AChEl protein as defined above.
- mRNA or genomic DNA mRNA or genomic DNA
- the subject of the present invention is also a method for detecting insects carrying resistance to insecticides of the organophosphate and carbamate class, characterized in that it comprises:
- Said detection is carried out by conventional techniques which are known in themselves, for example: (i) by amplification of a region of said ace-1 gene capable of containing a mutation, then detection of said mutation by sequencing or by digestion with a appropriate restriction enzyme, of the PCR product obtained, or else (ii) by hybridization with a labeled probe specific for a region of said ace-1 gene capable of containing a mutation, then direct detection of the mismatches and / or digestion by an enzyme appropriate restriction.
- a fragment of approximately 320 bp is amplified using the primers SEQ LD NO: 39 and SEQ CD NO: 40.
- SEQ LD NO: 39 and SEQ CD NO: 40 For example, in mosquitoes one obtains a fragment of sequence SEQ BD NO: 24 to 38 which exhibits mutations between mosquitoes sensitive and resistant to insecticides.
- SEQ BD NO: 24 to 38 which exhibits mutations between mosquitoes sensitive and resistant to insecticides.
- C. pipiens there are 3 substitutions in the sequence of resistant individuals, one of which introduces an EcoRI site.
- the analysis of the restriction profile after PCR amplification of the fragment K and digestion of the products obtained by EcoRI makes it possible to rapidly detect the ace-1 genotype in a population of C.
- RR resistant homozygotes
- SS homozygous sensitive
- RS heterozygous resistant individuals
- the mutation G119S in the third exon encoding the ace-1 gene which is responsible for the resistance to insecticides of the organophosphorus and carbamate class in mosquitoes is detected according to one of the following alternatives, respectively in mosquitoes of the species C. pipiens and An. gambiae:
- a 520 bp fragment of the third coding exon is amplified from genomic DNA, by PCR using the pair of primers Ex3dir and Ex3rev (SEQ ID NO: 58 and 59); the PCR fragment is digested with Alu I and the digestion product is separated by agarose gel electrophoresis, then the restriction profile thus obtained is analyzed: the presence of a 520 bp fragment corresponds to homozygous SS sensitive individuals, the presence of two fragments (357 bp and 163 bp) correspond to RR resistant homozygous individuals and the presence of 3 fragments (520 bp, 357 bp and 163 bp) correspond to RS resistant heterozygous individuals,
- a 541 bp fragment of the third coding exon is amplified from genomic DNA, by PCR using the pair of primers Ex3AGdir and Ex3AGrev (SEQ ID NO: 123 and 124); the PCR fragment is digested with Alu I and the digestion product is separated by agarose gel electrophoresis, then the restriction profile thus obtained is analyzed: the presence of two fragments (403 bp and 138 bp) is suitable for sensitive homozygous individuals SS, the presence of 3 fragments (253 bp, 150 bp and 138 bp) corresponds to homozygous individuals resistant to RR and the presence of 4 fragments (403 bp, 253 bp, 150 bp and 138 bp) corresponds to heterozygous individuals resistant to RS; since the 150 bp and 138 bp fragments co-migrate, the resistant homozygous and heterozygous individuals are detected respectively by
- a 194 bp fragment containing codon 119 of the third coding exon is amplified from genomic DNA by PCR using the pair of primers Moustdirl and Moustrevl (SEQ ID NO: 128 and 129); the PCR fragment is digested with Alu I and the digestion product is separated by agarose gel electrophoresis, then the restriction profile thus obtained is analyzed: the presence of two fragments (74 bp and 120 bp) correspond to homozygous RR resistant individuals, the presence of a single fragment (no digestion) corresponds to SS homozygous susceptible individuals and the presence of three fragments (194 bp, 74 bp and 120 bp) corresponds to heterozygous RS resistant individuals.
- the present invention also relates to a reagent for detecting insects carrying a resistance to organophosphates and / or to carbamates, characterized in that it is selected from the group consisting of: nucleic acid molecules and their fragments as defined above (probes, primers) and antibodies as defined above.
- the present invention also relates to a recombinant vector, characterized in that it comprises an insert selected from the group consisting of the nucleic acid molecules encoding an AChEl protein and their fragments as defined above.
- said recombinant vector is an expression vector in which said nucleic acid molecule or one of its fragments are placed under the control of regulatory elements for appropriate transcription and translation.
- vectors are constructed and introduced into host cells by conventional recombinant DNA and genetic engineering methods, which are known per se.
- Many vectors into which a nucleic acid molecule of interest can be inserted in order to introduce and maintain it in a eukaryotic or prokaryotic host cell are known in themselves; the choice of an appropriate vector depends on the intended use for this vector (for example replication of the sequence of interest, expression of this sequence, maintenance of the sequence in extrachromosomal form or else integration into the chromosomal material of the host ), as well as the nature of the host cell.
- viral vectors such as baculoviruses or non-viral vectors such as plasmids can be used.
- the ace-1 cDNA can be placed under the control of a constitutive promoter such as the 5C actin promoter, in an appropriate vector and said recombinant vector is introduced into cells of insect such as Drosophila cells (Schneider S2 cells).
- a constitutive promoter such as the 5C actin promoter
- the present invention also relates to prokaryotic or eukaryotic cells, modified by a recombinant vector as defined above; preferably these cells are insect cells.
- the recombinant vectors and the modified cells as defined above are useful in particular for the production of the proteins and peptides AChE1 according to the invention.
- the present invention also relates to a transgenic invertebrate animal, characterized in that it contains cells modified with at least one nucleic acid molecule as defined above; preferably said animal is an insect.
- Transgenic animals and modified cells as defined above are useful in particular for the screening of insecticidal substances and for the biological control against vectors of pathogens and harmful insects.
- the present invention also relates to a method of screening an insecticidal substance, characterized in that it comprises: a) bringing the test substance into contact with an AChEl protein selected from: an AChEl protein isolated according to invention, an extract of modified cells or a biological sample of a transgenic animal containing said protein AChEl, as defined above, in the presence of acetylcholine or one of its derivatives, b) measurement by any suitable means , of the acetylcholinesterase activity of the mixture obtained in a), and c) the selection of the substances capable of inhibiting said activity.
- an AChEl protein selected from: an AChEl protein isolated according to invention, an extract of modified cells or a biological sample of a transgenic animal containing said protein AChEl, as defined above, in the presence of acetylcholine or one of its derivatives
- b) measurement by any suitable means of the acetylcholinesterase activity of the mixture obtained in a
- the selection of the substances capable of inhibiting said activity
- the present invention also relates to a method of screening for an insecticidal substance, characterized in that it comprises:
- said screening methods use AChEl resistant to organophosphates or to carbamates or else cells or transgenic animals containing them.
- the present invention also relates to a reagent for screening for insecticidal substances, characterized in that it is selected from the group consisting of AChEl proteins, recombinant vectors, modified cells and transgenic animals as defined above.
- Insecticidal substances capable of inhibiting the acetylcholinesterase activity of AChEl proteins resistant to insecticides of the organophosphorus and carbamate class commonly used have applications: in human and animal health, to combat vectors of pathogens (for example Aedes aegypti, vector of arboviruses such as dengue and yellow fever, Culex pipiens vector of the West-Nile virus, Anopheles gambiae African vector of the malaria agent, etc.) and in the field of agriculture, to fight against harmful insects which devastate crops (for example the Colorado potato beetle (Leptinotarsa decemlineata) which attacks potatoes, aphid pests such as Aphis gossypii and Myzus persicae, etc.).
- the invention further relates to a detection and / or screening kit for the implementation of the methods as defined above, characterized in that it includes at least one reagent as defined above.
- the present invention also relates to a method of screening for inhibitors of an AChEl as defined above, characterized in that it comprises:
- step (b) isolating the potential inhibitors identified in step (a);
- step (c) bringing the substance isolated in step (b) into contact with an AChEl as defined above, an extract of modified cells, a biological sample from a transgenic animal as defined above or a insect extract sensitive or resistant to the aforementioned insecticides, in the presence of acetylcholine or one of its derivatives;
- the method according to the invention comprises a step (step (a)) of computer simulation aimed at identifying peptide or chemical structures having a significant probability of binding to a target protein.
- step (c) of the process It is thus possible to isolate potential inhibitors of the resistant AChEl form without biochemically having the protein, then to directly test the inhibition capacity of each candidate on the AChEl activity of an extract of sensitive insects or resistant (step (c) of the process). This approach can therefore completely dispense with the purification and / or production of target protein.
- the significance of a probability of binding cannot be defined in an absolute manner: it may depend on the type of amino acids involved in the interaction, as well as on the software used for modeling. More precisely, the most commonly used methods select, for a given site of a target molecule, the compounds having the lowest binding energy. In general, the energy calculation takes into account the “hydrogen” bonds, the van der Waals, electrostatic and hydrophobic interactions, as well as the entropy penalties. It is therefore a priori impossible to give a limit of significance in absolute value beyond which a potential ligand will be accepted or rejected, since the energy will depend on the atoms engaged in the bond. However, three selection criteria can be applied: 1. an arbitrary selection of the compounds of lower binding energy. In general, the limit is set between 1% and 5% of the number of compounds tested.
- an estimate of the affinity of the bond based on energy calculations.
- An acceptable value as a starting point could be understood between 1 and 300 micromolar.
- the onchidal, an AChE inhibitor has an apparent affinity of 300 ⁇ M (Abramson et al., Mol. Pharmacol., 1989, 36, 349).
- the invention also comprises other arrangements which will emerge from the description which follows, which refers to examples of implementation of the ace-1 gene and its products (cDNA, protein) according to the present invention as well as the table summarizing the sequences of the Application and the accompanying drawings in which: - Figure 1 illustrates the alignment of the amino acid sequences of the AChEl proteins of Anopheles gambiae, Schizaphis graminum, An.
- amino acids are numbered with reference to the AChE sequence of torpedo fish (Tor proceedingsdo califomica; SWISSPROT P04058). The N- and C-terminal sequences are not shown because of their variability.
- Amino acids stored between AChEl and AChE2 are shown in gray. The specific amino acids of AChE2 are indicated in black.
- the 3 residues representing the catalytic triad (S 200 , E 32 and H 440 ) are framed.
- the choline binding site (W 84 ) is underlined.
- the circles represent the position of the 14 aromatic residues bordering the throat of the active site in the AChE of Toroutheasterndo, 10 of which are present in all the AChEl and AChE2 (solid circles), the others not being conserved (empty circles). Three intramolecular disulfide bonds between cysteine residues are indicated.
- the horizontal arrow indicates the position of fragment K (amplified using the primers PdirAGSG and PrevAGSG). The hypervariable region of ACbE2 which is absent in AChEl is surrounded.
- FIG. 2 illustrates the genetic detection of mosquitoes resistant to organophosphates and / or to carbamates by PCR-RFLP: .
- FIG. 2A represents the comparison of the amino acid sequence of the K fragment of different mosquito species: Cx Pip (Culex pipiens), Ae alb ( ⁇ edes albopictus), Ae aeg (Aedes aegypti), An alb (Anopheles albimanus), An gamb (Anopheles gambiae), An fun (Anopheles funestus), An nil (Anopheles nili), An sac (Anopheles sacharovi), An pse (Anopheles pseudopunctipennis).
- Variant amino acids are grayed out.
- the following sequences are identical: An. Darlingi and An. Albimanus; An. Sundaicus, An. Gambiae and An. Arbiensis; An. Moucheti, An. Funestus and An. Minimus; An. Stephensi and An. Saccharovi.
- FIG. 2B illustrates the comparison of the nucleotide sequences corresponding to the fragment K of the sensitive (S-LAB) and resistant (SR) strains.
- the variant nucleotides are grayed out (t - »c in position 3; a -» g in position 84: the site.
- FIG. 2C illustrates the restriction profiles obtained after agarose gel electrophoresis of the EcoRI digestion products of the fragment K amplified by PCR.
- the homozygous susceptible strain S-LAB has a profile characterized by 2 bands (214 bp and 106 bp), the resistant homozygous strain has a profile characterized by a single band of 320 bp and the resistant mosquitoes from the back crossing have a heterozygous profile characterized by 3 bands (320 bp, 214 bp and 106 bp).
- - Figure 3 illustrates the phylogenetic tree of AChE proteins.
- Lcup Lucilia cuprina: Mdom: Musca domestica: Ldec: Leptinotarsa decemli- neata; Amel Apis mellifera: Ncin: Nephotettix cincticeps; Sgra: Schizaphis grami- num; Rapp: Rhipicephalus appendiculatus; Bmic: Boophilus microplus; Bdec: Boophilus decoloratus; Hsap: Homo sapiens; Btau: Bos taurus; Fcat: Félix catus; Ocunus Oryctus Rnor: Rattus norvegicus; Mmus: Mus musculus; Ggal: Gallus gallus; Drer: Danio reno; Eele: Electrophorus electricus; Tamr.- Tortigdo marmorata; Tcal: Tor proceedingsdo califomica; Bfas: Bungarus fasciatus; Mglu: Myxine glutinosa; Bflo
- FIG. 4 illustrates the cladogram of proteins AChEl and AChE2.
- the sequences of the proteins AChE1 and AChE2 were treated as in FIG. 1.
- the sequence Bmic was added as an external sequence to define the origin of the tree.
- the boxes marked with an asterisk represent proteins encoded by a gene that segregates with resistance to insecticides.
- the empty boxes represent the proteins encoded by a gene that does not segregate with resistance to insecticides.
- the scale corresponds to a divergence of 10%.
- FIGS. 1 illustrates the comparison of the amino acid sequences of the AChEl protein of C. pipiens, infers a strain sensitive (S-LAB) and a strain resistant (SR) to insecticides.
- S-LAB strain sensitive
- SR strain resistant
- the unique glycine 247 (// 9) -> serine 24 (y / P ) mutation (shown in gray) is responsible for resistance to insecticides in mosquitoes of the species C. pipiens; it corresponds to the substitution of the glycine located at position 247 of the AChEl sequence of C. pipiens (or at position 119, with reference to the AChE sequence of torpedo fish), by a serine.
- FIGS. 6A and 6B illustrate the comparison of the nucleotide sequences coding for the AChEl protein of C. pipiens, between a strain sensitive (S-LAB) and a strain resistant (SR) to insecticides; all mutations are silent with the exception of the mutation in position 739 (G - »A) which results, on the one hand, in the substitution of the glycine codon (GGC) in position 247 of the sequence of the protein AchEl of the sensitive strain (S-LAB) by a serine codon (AGC) responsible for resistance to insecticides in the strain SR, and on the other hand, the appearance of an Alu I site (AGCT) in the sequence of the resistant strain, useful for the detection of the mutation.
- GGC glycine codon
- AAC serine codon
- FIG. 7A illustrates (i) the overall structure of the two proteins and (ii) and the steric hindrance of the Van der Waals bonds of serine 200 and histidine 440 of the catalytic site of the enzyme, as well as that of the amino acid at position 119 which is mutated in the case of resistance; the residue in position 119 is close to the residues S 20 o and H 440 of the catalytic site.
- FIGS. 7B and 7C illustrate the comparison of the steric hindrance of the Van der Waals bonds of the amino acids glycine (FIG. 7C) and serine (FIG. 7B) in position 119, of the sensitive and resistant strain respectively.
- the size of the side chain of Serine in position 119 in the resistant strain reduces the space of the catalytic site which probably prevents the insecticide from interacting with catalytic serine (S 200 ).
- FIG. 8 illustrates the detection by PCR-RFLP of the glycine -> serine mutation in the third exon coding for the ace-1 gene, in mosquitoes of the species C.
- 1 band (520 bp) is detected in SS homozygous susceptible individuals, 2 bands (357 bp and 163 bp) are detected in RR resistant homozygous individuals and 3 bands (520 bp, 357 bp and 163 bp) are detected in RS resistant heterozygous individuals.
- FIGS 9A and 9B illustrate the comparison of the sequences of the ace-1 gene of An, gambiae, infers a strain sensitive (KISUMU) and a strain resistant (YAO) to insecticides; all mutations are silent with the exception of two mutations: the first involves the replacement of valine (CGT) in position 33 of the AChEl sequence of the sensitive strain (SEQ ED NO: 5) with an alanine (CGC) in the resistant strain and the second is the same glycine mutation (GGC) - »serine (AGC) as that found in Culex pipiens.
- CCT valine
- CGC alanine
- GGC glycine mutation
- AAC glycine mutation
- the glycine (GGC) ⁇ serine (AGC) mutation causes the appearance of a second Alu I site (AGCT) in the sequence of the third exon encoding the resistant strain, useful for detecting the mutation.
- the coding sequences of the ace-1 gene are indicated in bold and the mutations are indicated in gray.
- the sequences of the primers Ex3AGdir and Ex3Agrev used to detect the glycine mutation (GGC) - ⁇ - serine (AGC), as well as the Alu I sites of the fried exon coding are indicated in bold and underlined.
- FIG. 10 illustrates the quantification of the acetylcholinesterase activity of the AChEl recombinant proteins of Culex pipiens, sensitive (S-LAB, white banas) and resistant (SR, gray banas), produced in S2 insect cells, by comparison with that shredded C. pipiens strain S-LAB (hatched white bananas) and strain SR (shaded gray bars).
- the acetylcholinesterase activity of the cell extracts and of the mosquito grinds was measured in the absence (C) and in the presence of ÎO ⁇ M and 10 "2 M of propoxur.
- the only glycine 247 mutation (7 / 9d -> serine 24 (7 / 9d makes acetylcholinesterase insensitive to insecticide.
- FIG. 11 illustrates the detection by PCR-RFLP of the glycine - »serine mutation in the third exon coding for the ace-1 gene, in mosquitoes of the species Culex pipiens, Anopheles gambiae and Anopheles albimanus: 1 band (194 bp ) is detected in homozygous susceptible SS individuals, 2 bands (74 bp and 120 bp) are detected in homozygous RR resistant individuals and 3 bands (194 bp, 74 bp and 120 bp) are detected in heterozygous SS resistant individuals.
- FIG. 12 illustrates the quantification of the acetylcholinesterase activity of the AChEl proteins of respectively Culex pipiens, Anopheles gambiae and Anopheles albimanus sensitive (SS, gray stripes) and resistant (RS, black bands and RR, white bands).
- FIG. 13 shows the alignment of the nucleotide sequences of the 194 bp fragment of Anopheles gambiae, Culex pipiens and Anopheles albimanus, sensitive (S) or resistant (R).
- Light gray background sequences corresponding to the primers Moustdirl and Moustrevl.
- Gray background Alu I site.
- Dark gray background Guanine from the Gly codon of susceptible individuals.
- FIG. 14 shows the nucleotide sequences of the 194 bp fragment of sensitive (S) and resistant (R) Anopheles albimanus.
- the codon specifying Gly (GGC) and Ser (AGC) is in bold.
- the Alu I site is underlined. Table II; List of sequences
- SEQ ID NO: 1 fragment of the central region of the AChEl protein Anopheles gambiae (positions 70 to 593 of SEQ ID NO: 3).
- SEQ ID NO: 7 AChEl protein Culex pipiens strain S-LAB (complete sequence)
- SEQ ID NO: 26 nucleotide fragment K AChEl Aedes aegypti
- SEQ ID NO: 28 nucleotide fragment K AChEl Anopheles darlingi (AJ 438599)
- SEQ ID NO: 37 nucleotide fragment K AChEl An. Albimanus (AJ 538608)
- SEQ ID NO: 38 nucleotide fragment K AChEl An. ⁇ /// (AJ 538609)
- SEQ ID NO: 64 Nucleotide fragment of the third exon encoding the Praias-P-R strain
- SEQ ID NO: 65 Nucleotide fragment of the third exon encoding Supercar-Q-R strain
- SEQ ID NO: 70 Nucleotide fragment of the third exon coding strain Martinique-Q-R
- SEQ ID NO 90 (D SEQ ID NO 91 (D SEQ ID NO 92 (D SEQ ID NO 93 (D
- nucleotide sequences SEQ ED NO: 27 to 38
- corresponding peptide sequences SEQ ED NO: 10 to 21
- EXAMPLE 1 Materials and Methods a) Strains and Crosses Five strains of C. pipiens were used: S-LAB, a standard strain sensitive to insecticides (Georghiou et al., 1966, Bull. Wld. Hlth Org., 35, 691 -708), SA1, SA4 and EDIT which have a single AChE sensitive to insecticides, and SR which is homozygous for an AChE insensitive to insecticides (Berticat et al., Genêt. Res., 2002, 79, 41-47). The strains having a sensitive and insensitive AChE are called respectively S and R.
- ace-1 represents the locus coding for a cholinergic AChE responsible for resistance to organophosphates and / or to carbamates in C. pipiens (AChEl), previously called Ace.l (Raymond et al., Genetica, 2001, 112/113, 287-296).
- ace-2 represents the second ace locus, which is not involved in insecticide resistance in C. pipiens (previously called Ace.2), whose function is unknown in C. pipiens.
- the unique ace gene present in Drosophila melanogaster, which is homologous to ace-2, is therefore also named.
- the AChE genomic sequences of sea squirts were assembled from raw sequences deposited in the databases of the NCBI (Ciona savignyi) and the Doe Joint Institute (Ciona intestinalis, http://www.igi.doe.gov/ programs / ciona / ciona mainage.html
- the searches in the Drosophila databases were carried out using Flybase (http://www.fruitfly.org/) e) Sequence comparisons
- sequences of the AChEl and AChE2 proteins of Anopheles gambiae deduced from the genomic sequences and the peptide sequences deduced from PCR fragments of C. pipiens and A. aegypti were aligned with those of the known AChEs, using the ClustalW software, using a BLOSUM matrix and default parameters (Thompson et al., NAR, 1994, 22, 4673-4680).
- a phylogenetic tree was constructed using the neighbor-joining algorithm of the DDBJ version of Clustal W (http: //hypernig.nig.ac.ip/homology/ex_clustalw-e.shtml). Bootstrap analysis (1000 counts and 111 input values) was used to assess the confidence levels for the tree topology. The construction of the trees was carried out using Treeview software (vl.6.6). f) Accession numbers
- sequence numbers used for genetic analysis are as follows.
- - Craniata Homo sapiens: NP_00046; Bos taurus: P23795; Félix catus: 06763; Oryctolagus cuniculus: Q29499; Rattus norvegicus: P36136; Mus musculus: P21836; Gallus gallus: CAC37792; Danio reno: Q9DDE3; Electrophorus electricus: 6730113; Tordozensdo marmorata: P07692; Tor proceedingsdo califomica: P04058; Bungarus fasciatus: Q92035; Hagfish glutinosa: Q92081.
- - Cephalocordates Branchiostoma ⁇ oridae: 076998 and 076999;
- Branchiostoma lanceolatum Q95000 and Q95001.
- Ciona intestinalis SEQ ID NO: 51
- Ciona savignyi SEQ ID NO: 52.
- Caenorhabditis elegans (1 to 4): P38433, 061371, 061459 and 061372; Caenorhabditis briggsae (1 to 4) Q27459, O61378Q9NDG9 and
- Anopheles gambiae (1 and 2): SEQ ED NO: 3 and SEQ ED NO: 53 (BM 629847 and BM 627478); Aedes aegypti (1 and 2): SEQ ID NO: 9 and AAB3500; An.
- 30 PCR amplification cycles were carried out under the following conditions: 94 ° C for 30 s, 50 ° C for 30 s to and 72 ° C for 30 s.
- the sequences were determined directly on the PCR products on an ABI prism 310 sequencer, using the Big Dye Terminator kit.
- the genotyping of ace-1 in Culex is carried out under the following conditions: The K fragments obtained as described above are digested with EcoRI and the digestion product is separated by electrophoresis on a 2% agarose gel. The restriction profiles show: 1 band (320 bp) in homozygous RR resistant mosquitoes, 2 bands (106 bp and 214 bp) in SS homozygous mosquitoes and 3 bands (103 bp, 214 bp and 320 bp) in heterozygous RS mosquitoes. h) Cloning of the ace-1 cDNA in sensitive and resistant individuals
- Culex pipiens ace-1 gene cDNA was obtained from RNA extracted from individuals of the sensitive reference strain S-LAB and the resistant strain SR, at the very early stage of L1 larval development. Reverse transcription was performed with an 18T oligonucleotide and SuperScriptlERNaseH (EN VITROGEN), according to the conditions recommended by the manufacturer.
- Two cDNA fragments were amplified by PCR using degenerate oligonucleotides obtained from the alignment of the sequences of the ace-1 genes of Anopheles gambiae and Schizaphis graminum:
- fragments b and k thus obtained were then cloned and sequenced, according to conventional techniques known in themselves to those skilled in the art, as described in Cunent Protocols in Molecular Biology (Frederick M. AUSUBEL, 2000, Wiley and son Inc, Library ofCongress, USA).
- a larger cDNA fragment was amplified by PCR, using primers specific for Culex pipiens deduced from the sequences of fragments b and k previously obtained. To know :
- the ends of the cDNAs were amplified by the RACE technique (Rapid Amplification ofcDNA Ends), using a commercial kit (from the Gene Racer kit (IN VITROGEN) according to the conditions indicated in the user manual. were cloned and then sequenced, as above, - strain SR
- the complete sequence of the cDNA of the ace-1 gene of the resistant strain SR was amplified by PCR using the primers culex-5'dir (5 - CCACACGCCAGAAGAAAAGA-3 ', SEQ ID NO: 54) and culex- 3'dir (5'- AAAAACGGGAACGGGAAAG-3, SEQ ID NO: 55) and the 2497 bp fragment thus obtained was cloned and sequenced, as above, i) Cloning of the ace-1 gene in susceptible and resistant individuals
- - fragment A (1130 bp) was amplified using the pair of primers AGl-Adir (5'CGACGCCACCTTCACA3 ⁇ SEQ ED NO: 45) and AGl-Arev (5'GATGGCCCGCTGGAACAGAT3 ', SEQ ED NO: 46), - fragment B (1167 bp) was amplified using the pair of primers AGl-Bdir (5'GGGTGCGGGACAACATTCAC3 ', SEQ BD NO: 47) and AGl-Brev (5'CCCCGACCGACGAAGGA3 ⁇ SEQ ED NO: 48), and
- sequences of fragments A, B and C were determined directly on the PCR products, using internal oligonucleotides, included in these fragments, using the Big Dye Terminator kit and an ABI prism 310 sequencer. J) detection of the mutation of the third coding exon responsible for resistance to insecticides in mosquitoes of the species C. pipiens and An. gambiae
- the mosquito DNA was extracted as described in Rogers et al., Supra, then a fragment of the crumbling exon coding was amplified by PCR, sequence and the mutation in the coding sequence of the third coding exon was detected by PCR-RFLP , according to the principle as described above for fragment K.
- a 520 bp fragment of the third coding exon was amplified from the genomic DNA of several mosquitoes, by PCR using the pair of primers: - Ex3dir 5 * -CGACTCGGACCCACTGGT-3 '(SEQ ED NO: 58 ) and
- the fragment thus obtained was digested with Alu I and the digestion product separated by electrophoresis on a 2% agarose gel.
- the expected restriction profiles are as follows: 1 fragment (520 bp) in SS-sensitive homozygous individuals, 2 fragments (357 bp and 163 bp) in RR-resistant homozygous individuals and 3 fragments (520 bp, 357 bp and 163 bp) in RS resistant heterozygous individuals.
- a 541 bp fragment of the third coding exon was amplified from the genomic DNA of several individuals, by PCR using the pair of primers:
- the fragment thus obtained was digested with Alu I and the product separated by elecfrophoresis on a 2% agarose gel.
- the expected restriction profiles are as follows: 2 fragments (403 bp and 138 bp) in SS homozygous susceptible individuals, 3 fragments (253 bp, 150 bp and 138 bp) in RR resistant homozygous individuals and 4 fragments (403 bp, 253 bp, 150 bp and 138 bp) in heterozygous individuals resistant to RS; since the 150 bp and 138 bp fragments co-migrate, the resistant homozygous and heterozygous individuals are detected respectively by the presence of 2 bands (253 bp and approximately 150 bp) and 3 bands (403 bp, 253 bp and approximately 150 bp) in agarose gel.
- a 174 bp fragment of the third coding exon was amplified from the genomic DNA of several mosquitoes, by PCR using the pair of primers: - Moustdirl: 5 'CCGGGNGCSACYATGTGGAA 3' (SEQ ED
- the fragment thus obtained was digested with Alu I and the digestion product separated by elecfrophoresis on a 2% agarose gel.
- the expected restriction profiles are as follows: 1 fragment (194 bp) in SS-sensitive homozygous individuals, 2 fragments (74 bp and 120 bp) in RR-resistant homozygous individuals and 3 fragments (194 bp, 74 bp and 120 bp) in RS resistant heterozygous individuals. The results are illustrated in Figure 11.
- FIG. 12 shows that the same inhibitory characteristics with propoxur are obtained with resistant mosquitoes An. Albimanus by conventional biochemical test as for the mosquitos An. Gambiae and C. pipiens.
- the cDNAs encoding the AchE1s of the S-LAB strain and the SR strain respectively were cloned into the eukaryotic expression vector pAc5.1 / V5-His (ENVITROGEN), according to conventional recombinant DNA techniques according to standard protocols. such as those described in Current Protocols in Molecular Biology, supra.
- Drosophila cells (Schneider S2 cells) were transfected with the recombinant vectors thus obtained, using the Fugen® reagent (ROCHE), following the manufacturer's instructions. 24 hours after transfection, the cells were harvested by centrifugation and then lysed in 0.25M phosphate buffer containing 1% Triton X-100.
- acetylcholinesterase activity of the cell extracts obtained was measured, in the presence or in the absence of insecticide (propoxur), by the method as described in Bourguet et al., Biochemical Genetics, 1996, 34, 351-362.
- Amino acid sequence analysis confirms that the AChEl and AChE2 proteins are very homologous to Drosophila AChE (BLASTP: P ⁇ e " 18 °) and contain a canonical FGESAG motif around the serine at position 200, with reference to the sequence of the Ache de Torcherdo (S 20 o figure 1), which is characteristic of the active AchE site.
- AChE characteristic patterns of AChE were also found in the two sequences (AChEl and AChE2): the choline binding site (Tryptophan residue at position 84, W84), the three residues of the catalytic triad (serine residues , glutamic acid and histidine, respectively in positions 200, 327 and 440: S 200 , E 327 and H 440 ), the six cysteine residues potentially involved in conserved disulfide bridges (C 67 -C 94 ; C 254 -C 265 ; C 4 o 2 -C 521 ), and aromatic residues bordering the throat of the active site (10 and 11 residues, respectively for AChEl and AChE2).
- the proteins AChEl and AChE2 of An, gambiae have 53% similarity between them and show respectively: 76% and 55% of similarity with the AChE of Schizaphis graminum (accession number NCBI AAK09373 or GENBANK 12958609), 53% and 98% similarity with AChE from An, stephensi (GENBANK 2494391), 54% and 95% similarity with AChE from Aedes aegypti (GENBANK 2133626), 52% and 83% similarity with AChE from Drosophila (GENBANK 17136862).
- EXAMPLE 4 Demonstration of at least two ace genes in other mosquito species
- the presence of the ace-1 gene in the genome of other mosquito species was analyzed by PCR using degenerate oligonucleotides (PdirAGSG and PrevAGSG, SEQ BD NO: 39 and 40) making it possible to amplify an exonic fragment (fragment K, of approximately 320 bp in figure 1), corresponding to sequences conserved between the AChEl sequences of An, gambiae and Schizaphis graminum but divergent violates the AChEl and AChE2 sequences of An, gambiae.
- degenerate oligonucleotides PdirAGSG and PrevAGSG, SEQ BD NO: 39 and 40
- EXAMPLE 5 Analysis of the binding between the ace-1 gene and insecticide resistance
- the fragment K amplified from the genomic DNA of C. resistant pipiens (strain R) has been sequenced.
- the comparison of the sequences of fragment K between the strains S and R shows differences at the level of 3 nucleotides (silent substitutions, FIG. 2B).
- the link between the ace-1 gene and resistance to propoxur was studied, in triplicate, as follows: back-crossing larvae (S x R) x S were treated with a lethal dose for individuals susceptible and the ace-1 genotype was analyzed in the survivors by PCR-RFLP.
- Phylogenetic trees were constructed from the sequences of the conserved regions of the AChEs of An gambiae (SEQ ED NO: 1 and fragment 34-393 of the sequence SEQ ED NO: 53, FIG. 1), K fragments of C. pipiens and Aedes aegypti (SEQ ED NO: 8 and 9) and 33 AChE sequences available in GENBANK, using the neighbor-joining method, as described in the materials and methods.
- Figure 3 illustrates the heterogeneity of the number of ace genes during the evolution of the animal kingdom. In strings, cephalocords have at least two ace genes while urocords have only one, as deduced from the analysis of their genome.
- the dipterans In arthropods, the dipterans have either a single ace gene (Drosophila of the suborder Brachycera) or two ace genes (mosquitoes of the Suborder nematocera). The topology of the tree shows that these two ace genes duplicated very early during evolution, probably before the separation between the protostomes and the deuterostomes. These results are supported by the fact that the AChE of molluscs, nematodes and arthropods branch out from the sequences of the cords (craniatia, cephalocordates and urocordes). The results show that arthropods and nematodes have a related AChE.
- the ace-1 cDNA was cloned from two strains of Anopheles gambiae (strain KISUMU sensitive and strain YAO resistant) and two strains of Culex pipiens (strain S-LAB sensitive and strain SR resistant), as described in materials and methods.
- the complete sequence of the cDNA of the KISUMU strain corresponds to the sequence SEQ ID NO: 125 which codes for a protein of 737 amino acids (SEQ ID NO: 126).
- the complete sequence of the cDNA and of the AChEl protein of the YAO strain corresponds respectively to the sequences SEQ BD NO: 121 and SEQ ED NO: 122.
- sequences SEQ ED NO: 4 and SEQ ED NO: 5 correspond to the quasi sequence -complete (with the exception of the first exon coding for the ace-1 gene), respectively of the cDNA and of the AChEl protein of the KISUMU strain.
- the complete cDNA sequence of the S-LAB and SR strains of C. pipiens corresponds respectively to the sequences SEQ ID NO: 6 and SEQ ID NO: 56 which code for a protein of 702 amino acids (SEQ ED NO: 7 and SEQ ID NO: 57, respectively for the strain S-LAB and the strain SR).
- EXAMPLE 8 Determination of the sequence of the ace-1 gene
- the sequence of the ace-1 gene was determined from the genomic DNA of two strains of Anopheles gambiae, the sensitive reference strain of West Africa (strain KISUMU) and a resistant strain of Côte d ' ivory (YAO strain), as described in the materials and methods.
- the complete sequence of An, gambiae corresponds to the sequence SEQ
- ID NO: 127 which presents an intron-exon organization comprising at least 9 exons and including two 5 'non-coding exons (Table I)
- the almost complete sequence (with the exception of the first two non-coding 5 ′ exons) of the ace-1 gene of the KISUMU strain corresponds to the sequence SEQ JD NO: 23.
- the almost complete sequence (with the exception of the first two 5 'non-coding exons and the first coding exon) of the ace-1 gene of the YAO strain corresponds to the sequence SEQ ED NO: 120.
- EXAMPLE 9 Identification of mutation (s) in the amino acid sequence of the protein AChEl, responsible for resistance to insecticides in mosquitoes of the species Culex pipiens e Anophactuates gambiae.
- the nucleotide sequence encoding the AChEl protein was determined from two strains of Anopheles gambiae (strain KISUMU sensitive and strain YAO resistant) and two strains of Culex pipiens (strain S-LAB sensitive and strain SR), as described in Example 7.
- FIG. 7A shows that the amino acid in position 119 is close to the residues of the catalytic site (S 00 and H 440 ).
- FIG. 7C shows that, by comparison with the glycine of the sensitive strain (FIG. 7B), the size of the side chain of the serine of the resistant strain, reduces the space of the catalytic site, which probably prevents the insecticide d '' interact with catalytic serine (S 200 ).
- GGC glycine
- APC glycine- serine
- Table III Strains and populations of the species C. pipiens analyzed
- Table IV Analysis of the origin of the glycine - serine mutation responsible for resistance to insecticides in mosquitoes of the species C. pipiens
- Sensitive strains KISUMU (sensitive reference strain from East Africa) and VK-PER (reference strain KDR from West Africa) as well as sensitive populations from the Yaoundé region were tested by the PCR-RFLP test as described above.
- the recombinant AchE1s of the S-LAB strain and the SR strain respectively were expressed in insect cells and the acetylcholinesterase activity was measured from the cell extracts as described in Example 1.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003263246A AU2003263246A1 (en) | 2002-06-20 | 2003-06-19 | Novel acetylcholinesterase gene responsible for insecticide resistance and applications thereof |
CA002489617A CA2489617A1 (fr) | 2002-06-20 | 2003-06-19 | Nouveau gene de l'acetylcholinesterase responsable de la resistance aux insecticides et ses applications |
EP03760744A EP1521836A2 (fr) | 2002-06-20 | 2003-06-19 | Gene de l'acetylcholinesterase responsable de la resistance aux insecticides et ses applications |
US10/518,072 US8198061B2 (en) | 2002-06-20 | 2003-06-19 | Acetylcholinesterase gene responsible for insecticide resistance and applications thereof |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR02/07622 | 2002-06-20 | ||
FR0207622A FR2841259B1 (fr) | 2002-06-20 | 2002-06-20 | Nouveau gene de l'acetylcholinesterase responsable de la resistance aux insecticides et ses applications |
FR0213799A FR2846666B1 (fr) | 2002-11-05 | 2002-11-05 | Nouveau gene de l'acetylcholinesterase responsable de la resistance aux insecticides et ses applications |
FR02/13799 | 2002-11-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004000994A2 true WO2004000994A2 (fr) | 2003-12-31 |
WO2004000994A3 WO2004000994A3 (fr) | 2004-06-10 |
Family
ID=30001928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2003/001876 WO2004000994A2 (fr) | 2002-06-20 | 2003-06-19 | Nouveau gene de l'acetylcholinesterase responsable de la resistance aux insecticides et ses applications |
Country Status (5)
Country | Link |
---|---|
US (1) | US8198061B2 (fr) |
EP (1) | EP1521836A2 (fr) |
AU (1) | AU2003263246A1 (fr) |
CA (1) | CA2489617A1 (fr) |
WO (1) | WO2004000994A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009536020A (ja) * | 2006-02-23 | 2009-10-08 | フリーズランド ブランズ ビー.ブイ. | 超臨界媒体を使用する乾燥された粒子の調製方法 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020081765A1 (fr) * | 2018-10-18 | 2020-04-23 | Academia Sinica | Procédé et kit pour la détection de pesticides, et plasmide, baculovirus, cellule et leur procédé de préparation pour la détection de pesticides |
CN114672577B (zh) * | 2022-04-27 | 2023-06-13 | 青岛农业大学 | 一种检测具有耐AChE抑制剂性状的桔小实蝇的方法 |
CN116004850A (zh) * | 2022-10-31 | 2023-04-25 | 西北农林科技大学 | 蚜虫乙酰胆碱酯酶突变的lamp检测引物组及其用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2773802B1 (fr) * | 1998-01-22 | 2000-04-28 | Pasteur Institut | Polypeptide de fusion comprenant une acetylcholinesterase monomerique liee a un recepteur proteique et polynucleotide codant pour un tel polypeptide. application a la detection de molecules ligand |
-
2003
- 2003-06-19 EP EP03760744A patent/EP1521836A2/fr not_active Withdrawn
- 2003-06-19 US US10/518,072 patent/US8198061B2/en not_active Expired - Fee Related
- 2003-06-19 AU AU2003263246A patent/AU2003263246A1/en not_active Abandoned
- 2003-06-19 WO PCT/FR2003/001876 patent/WO2004000994A2/fr not_active Application Discontinuation
- 2003-06-19 CA CA002489617A patent/CA2489617A1/fr not_active Abandoned
Non-Patent Citations (29)
Title |
---|
BOURGUET D ET AL: "EXISTENCE OF TWO ACETYLCHOLINESTERASES IN THE MOSQUITO CULEX PIPIENS (DIPTERA: CULICIDAE)" JOURNAL OF NEUROCHEMISTRY, NEW YORK, NY, US, vol. 67, no. 5, 1996, pages 2115-2123, XP008013364 ISSN: 0022-3042 cité dans la demande * |
BOURGUET DENIS ET AL: "Analysis of molecular forms and pharmacological properties of acetylcholinesterase in several mosquito species." NEUROCHEMISTRY INTERNATIONAL, vol. 31, no. 1, 1997, pages 65-72, XP002234927 ISSN: 0197-0186 * |
BOURGUET DENIS ET AL: "Determination of Ace: 1. Genotypes in single mosquitoes: Toward an ecumenical biochemical test." PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, vol. 55, no. 2, 1996, pages 122-128, XP002234924 ISSN: 0048-3575 * |
BOURGUET DENIS ET AL: "Duplication of the Ace.1 locus in Culex pipiens mosquitoes from the Caribbean." BIOCHEMICAL GENETICS, vol. 34, no. 9-10, 1996, pages 351-362, XP008015132 ISSN: 0006-2928 * |
DATABASE EMBL [Online] 1 mars 2002 (2002-03-01), R.A. HOLT ET AL: "17000687086124 A. gam.ad.cDNA . blood1 Anopheles gambiae cDNA clone 19600449729584 5', mRNA sequence" XP002234942 extrait de EBI, HINXTON,UK Database accession no. BM608195 * |
DATABASE EMBL [Online] 15 août 2002 (2002-08-15), P.P. FORT: "aedes aegypti partial achE1 gene for acetylcholiesterase" XP002234946 extrait de EBI, HINXTON, UK Database accession no. AJ428049 * |
DATABASE EMBL [Online] 15 août 2002 (2002-08-15), P.P. FORT: "Culex pipiens partial achE1 gene for acetylcholinesterase, strain S-LAB" XP002234945 extrait de EBI, HINXTON, UK Database accession no. AJ428047 * |
DATABASE EMBL [Online] 15 août 2002 (2002-08-15), P.P. FORT: "Culex pipiens partial achE1 gene for acetylcholinesterase, strain SR" XP002234947 extrait de EBI, HINXTON, UK Database accession no. AJ428048 * |
DATABASE EMBL [Online] 16 août 2002 (2002-08-16), FAI LI ET AL: "Aphis gossipii clone ace 2 acetylcholinesterase mRNA, complete cds" XP002248004 extrait de EBI, HINXTON, UK Database accession no. AF502082 -& FAI LI ET AL: "Two different genes encoding acetylcholinesterase existing in cotton aphid" GENOME, vol. 45, no. 6, 1 novembre 2002 (2002-11-01), pages 1134-1141, XP008013411 * |
DATABASE EMBL [Online] 17 mars 2003 (2003-03-17), M. WEILL ET AL: "Culex pipiens mRNA for acetylcholinesterase (achE1 gene), strain SR" XP002248010 extrait de EBI, HINXTON, UK Database accession no. AJ515147 -& M. WEILL ET AL: "comparative genomics Insecticide resistance in mosquito vectors" NATURE, vol. 423, 8 mai 2003 (2003-05-08), pages 136-137, XP0002269568 * |
DATABASE EMBL [Online] 19 février 2001 (2001-02-19), J.R. GAO ET AL: "Schizapis graminum acetylcholinesterase precursor, mRNA, complete cds" XP002234929 extrait de EBI, HINXTON, UK Database accession no. AF321574 -& J.R. GAO ET AL: "Molecular cloning and characterization of a greenbug (Schizaphis graminum) cDNA encoding acetylcholinesterase possibly evolved from a duplicate gene lineage" INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY, vol. 32, no. 7, juillet 2002 (2002-07), pages 765-775, XP002234922 * |
DATABASE EMBL [Online] 30 mai 2002 (2002-05-30), P.P. FORT: "Aedes albopictus partial achE1 gene for acetylcholinesterase" XP002234930 extrait de EBI, HINXTON, UK Database accession no. AJ438598 cité dans la demande * |
DATABASE EMBL [Online] 30 mai 2002 (2002-05-30), P.P. FORT: "Anopheles albimanus partial achE1 gene for acetylcholinesterase" XP002234938 extrait de EBI, HINXTON, UK Database accession no. AJ438608 cité dans la demande * |
DATABASE EMBL [Online] 30 mai 2002 (2002-05-30), P.P. FORT: "Anopheles arabiensis partial achE1 gene for acetylcholinesterase" XP002234934 extrait de EBI, HINXTON, UK Database accession no. AJ438603 cité dans la demande * |
DATABASE EMBL [Online] 30 mai 2002 (2002-05-30), P.P. FORT: "Anopheles darlingi partial achE1 gene for acetylcholinesterase" XP002234931 extrait de EBI, HINXTON, UK Database accession no. AJ438599 cité dans la demande * |
DATABASE EMBL [Online] 30 mai 2002 (2002-05-30), P.P. FORT: "Anopheles funestus partial achE1 gene for acetylcholinesterase" XP002234933 extrait de EBI, HINXTON, UK Database accession no. AJ438604 cité dans la demande * |
DATABASE EMBL [Online] 30 mai 2002 (2002-05-30), P.P. FORT: "anopheles minimus partial achE1 gene for acetylcholinesterase" XP002234935 extrait de EBI, HINXTON, UK Database accession no. AJ438601 cité dans la demande * |
DATABASE EMBL [Online] 30 mai 2002 (2002-05-30), P.P. FORT: "Anopheles moucheti partial achE1 gene for acetylcholinesterase" XP002234937 extrait de EBI, HINXTON, UK Database accession no. AJ438602 cité dans la demande * |
DATABASE EMBL [Online] 30 mai 2002 (2002-05-30), P.P. FORT: "Anopheles nili partial achE1 gene for acetylcholinesterase" XP002234941 extrait de EBI, HINXTON, UK Database accession no. AJ438609 cité dans la demande * |
DATABASE EMBL [Online] 30 mai 2002 (2002-05-30), P.P. FORT: "Anopheles pseudopunctipennis partial achE1 gene for acetylcholinesterase" XP002234936 extrait de EBI, HINXTON, UK Database accession no. AJ438605 cité dans la demande * |
DATABASE EMBL [Online] 30 mai 2002 (2002-05-30), P.P. FORT: "anopheles sachavori partial achE1 genefor acetylcholinesterase" XP002234939 extrait de EBI, HINXTON, UK Database accession no. AJ438606 cité dans la demande * |
DATABASE EMBL [Online] 30 mai 2002 (2002-05-30), P.P. FORT: "anopheles stephensi partial achE1 gene for acetylcholinesterase" XP002234940 extrait de EBI, HINXTON , UK Database accession no. AJ438607 cité dans la demande * |
DATABASE EMBL [Online] 30 mai 2002 (2002-05-30), P.P. FORT: "Anopheles sundaicus partial achE1 gene for acetylcholinesterase" XP002234932 extrait de EBI, HINXTON, UK Database accession no. AJ438600 cité dans la demande * |
DATABASE EMBL [Online] 7 novembre 2002 (2002-11-07), P.P. FORT: "Anopheles gambiae partial achE1 gene for acetylcholinesterase, exons 4-9" XP002234943 extrait de EBI, HINXTON, UK Database accession no. AJ488492 * |
MALCOLM C A ET AL: "A sex-linked Ace gene, not linked to insensitive acetylcholinesterase-mediated insecticide resistance in Culex pipiens." INSECT MOLECULAR BIOLOGY, vol. 7, no. 2, mai 1998 (1998-05), pages 107-120, XP002234923 ISSN: 0962-1075 * |
MUTERO ANNICK ET AL: "Resistance-associated point mutations in insecticide-insensitive acetylcholinesterase." PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 91, no. 13, 1994, pages 5922-5926, XP002234925 1994 ISSN: 0027-8424 cité dans la demande * |
N. ANTHONY ET AL: "Cloning, sequencing and functional expression of an acetylcholinesterase gene from the yellow fever mosquito Aedes aegypti" FEBS LETTERS, vol. 368, 1995, pages 461-465, XP002234926 * |
S.B. WALSH ET AL: "Identification and characterization of mutations in housefly (Musca domestica) acetylcholinesterase involved in insecticide resistance" BIOCHEMICAL JOURNAL, vol. 359, 2001, pages 175-181, XP002234928 cité dans la demande * |
WEILL MYLENE ET AL: "A novel acetylcholinesterase gene in mosquitoes codes for the insecticide target and is non-homologous to the ace gene in Drosophila." PROCEEDINGS OF THE ROYAL SOCIETY BIOLOGICAL SCIENCES SERIES B, vol. 269, no. 1504, 7 octobre 2002 (2002-10-07), pages 2007-2016, XP008015105 ISSN: 0962-8452 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009536020A (ja) * | 2006-02-23 | 2009-10-08 | フリーズランド ブランズ ビー.ブイ. | 超臨界媒体を使用する乾燥された粒子の調製方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2004000994A3 (fr) | 2004-06-10 |
US20080256649A1 (en) | 2008-10-16 |
AU2003263246A1 (en) | 2004-01-06 |
AU2003263246A8 (en) | 2004-01-06 |
EP1521836A2 (fr) | 2005-04-13 |
US8198061B2 (en) | 2012-06-12 |
CA2489617A1 (fr) | 2003-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Schoville et al. | A model species for agricultural pest genomics: the genome of the Colorado potato beetle, Leptinotarsa decemlineata (Coleoptera: Chrysomelidae) | |
Kwon et al. | A point mutation in a glutamate‐gated chloride channel confers abamectin resistance in the two‐spotted spider mite, Tetranychus urticae Koch | |
Lynch | Inventing an arsenal: adaptive evolution and neofunctionalization of snake venom phospholipase A 2 genes | |
Kozma et al. | Chemoreceptor proteins in the Caribbean spiny lobster, Panulirus argus: expression of ionotropic receptors, gustatory receptors, and TRP channels in two chemosensory organs and brain | |
Pezzementi et al. | Evolution of acetylcholinesterase and butyrylcholinesterase in the vertebrates: an atypical butyrylcholinesterase from the Medaka Oryzias latipes | |
Magaña et al. | Mechanisms of resistance to malathion in the medfly Ceratitis capitata | |
Adedeji et al. | Anopheles metabolic proteins in malaria transmission, prevention and control: a review | |
Ren et al. | A selenium-dependent glutathione peroxidase (Se-GPx) and two glutathione S-transferases (GSTs) from Chinese shrimp (Fenneropenaeus chinensis) | |
Bourguet et al. | Variation of dominance of newly arisen adaptive genes | |
Francischetti et al. | Insight into the sialome of the bed bug, Cimex lectularius | |
Weinberger et al. | Positions under positive selection—key for selectivity and potency of scorpion α-toxins | |
Newcomb et al. | Multiple mutations and gene duplications conferring organophosphorus insecticide resistance have been selected at the Rop-1 locus of the sheep blowfly, Lucilia cuprina | |
Becchimanzi et al. | Venomics of the ectoparasitoid wasp Bracon nigricans | |
Seong et al. | Identification and characterization of three cholinesterases from the common bed bug, Cimex lectularius | |
FR2780405A1 (fr) | Nouveaux recepteurs olfactifs et leurs utilisations | |
Neveu et al. | Molecular cloning and characterization of an intestinal cathepsin L protease from the plant-parasitic nematode Meloidogyne incognita | |
Rauch et al. | Characterization and molecular cloning of a glutathione S-transferase from the whitefly Bemisia tabaci (Hemiptera: Aleyrodidae) | |
Zhu et al. | Comparative study on glutathione S-transferase activity, cDNA, and gene expression between malathion susceptible and resistant strains of the tarnished plant bug, Lygus lineolaris | |
Bae et al. | Modular evolution of glutathione peroxidase genes in association with different biochemical properties of their encoded proteins in invertebrate animals | |
WO2004000994A2 (fr) | Nouveau gene de l'acetylcholinesterase responsable de la resistance aux insecticides et ses applications | |
Boland | Sequestration of plant-derived glycosides by leaf beetles: a model system for evolution and adaptation | |
Prijatelj et al. | Mapping the structural determinants of presynaptic neurotoxicity of snake venom phospholipases A2 | |
Kishimura et al. | cDNA cloning and sequencing of phospholipase A2 from the pyloric ceca of the starfish Asterina pectinifera | |
FR2846666A1 (fr) | Nouveau gene de l'acetylcholinesterase responsable de la resistance aux insecticides et ses applications | |
FR2841259A1 (fr) | Nouveau gene de l'acetylcholinesterase responsable de la resistance aux insecticides et ses applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2489617 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003760744 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003760744 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10518072 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |